MAPT and Alzheimer disease: While the inclusion criteria for the study was extensive to confirm amnestic MCI, subjects were not required to have evidence of amyloid or tau pathology, thus the application of these findings to MCI patients on the AD continuum can be considered an extrapolation on the basis that a clinical diagnosis of amnestic MCI is the same regardless of the underlying disease pathology.